Two Health Care Stocks That Could Cause You Concern This December
Avidity Biosciences Overview: Avidity Biosciences reported a quarterly loss of $1.27 per share, missing estimates, but its sales of $12.475 million exceeded expectations. The stock has surged 141% over six months, with an RSI of 76, indicating it may be overbought.
Henry Schein Overview: Henry Schein received an Overweight rating from Barclays with a price target of $86. The stock has increased by 6% recently and has a 52-week high of $82.49, with an RSI of 71.1, suggesting it is also nearing overbought territory.
Momentum Indicator Explanation: The Relative Strength Index (RSI) is a momentum indicator that helps traders assess stock performance by comparing price strength on up days versus down days, with values above 70 indicating overbought conditions.
Market Context: The article highlights the potential risks for investors in the health care sector, particularly focusing on stocks that may be overvalued based on their momentum indicators.
Get Free Real-Time Notifications for Any Stock
Analyst Views on PAVS
About PAVS
About the author

Paranovus Regains Nasdaq Compliance, Hearing Canceled
- Compliance Restoration: Paranovus Entertainment Technology received notification on January 6, 2026, confirming compliance with Nasdaq's minimum bid price requirement under Listing Rule 5550(a)(2), ensuring continued listing and trading of its shares on Nasdaq, thus avoiding potential delisting risks.
- Hearing Cancellation: The scheduled hearing on January 29, 2026, was canceled due to the resolution of compliance issues, which not only alleviates pressure on the company's management but also provides greater flexibility for its future strategic transformation.
- Strategic Transformation: After exiting legacy businesses in September 2023, Paranovus is focusing on e-commerce and TikTok-related solutions, which is expected to enhance its market competitiveness and attract more investor interest through its new business model.
- Acquisition Integration: The completion of the acquisition of controlling equity interests in Bomie Wookoo Inc. in March 2025 further strengthens its position in the e-commerce sector, anticipated to drive future revenue growth and increase market share.

Paranovus Regains Nasdaq Compliance, Hearing Canceled
- Compliance Restoration: Paranovus Entertainment Technology received notification on January 6, 2026, from Nasdaq confirming compliance with the minimum bid price requirement under Listing Rule 5550(a)(2), thereby canceling the scheduled hearing on January 29 and ensuring continued trading of its shares on Nasdaq.
- Strategic Transformation: The company completed the acquisition of controlling equity interests in Bomie Wookoo Inc. in March 2025, focusing on e-commerce and TikTok-related solutions, which marks a successful pivot from its legacy businesses and enhances its competitive edge in the market.
- Business Exit: Paranovus exited its legacy e-commerce, internet information, and advertising businesses in September 2023 and ceased its automobile sales business in July 2024, aiming to concentrate resources on the more promising e-commerce sector and optimize resource allocation.
- Market Positioning: By focusing on e-commerce and TikTok-related solutions, Paranovus aims to leverage the rapidly growing social commerce market, enhancing brand influence and capturing opportunities arising from emerging consumer trends.









